Shufro Rose & Co. LLC increased its position in Express Scripts Holding Company (NASDAQ:ESRX) by 9.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,474 shares of the company’s stock after acquiring an additional 2,100 shares during the quarter. Shufro Rose & Co. LLC’s holdings in Express Scripts Holding were worth $1,562,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in ESRX. Waldron LP bought a new position in shares of Express Scripts Holding in the first quarter valued at approximately $206,000. Oakworth Capital Inc. boosted its position in shares of Express Scripts Holding by 7.0% in the first quarter. Oakworth Capital Inc. now owns 2,362 shares of the company’s stock valued at $155,000 after acquiring an additional 155 shares during the period. Dillon & Associates Inc. boosted its position in shares of Express Scripts Holding by 5.6% in the first quarter. Dillon & Associates Inc. now owns 6,735 shares of the company’s stock valued at $445,000 after acquiring an additional 355 shares during the period. Meyer Handelman Co. boosted its position in shares of Express Scripts Holding by 1.8% in the first quarter. Meyer Handelman Co. now owns 12,833 shares of the company’s stock valued at $846,000 after acquiring an additional 233 shares during the period. Finally, Old Mutual Global Investors UK Ltd. boosted its position in shares of Express Scripts Holding by 311.4% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 2,157,210 shares of the company’s stock valued at $142,181,000 after acquiring an additional 1,632,801 shares during the period. Institutional investors own 88.71% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Shufro Rose & Co. LLC Has $1.56 Million Stake in Express Scripts Holding Company (ESRX)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/09/07/shufro-rose-co-llc-has-1-56-million-stake-in-express-scripts-holding-company-esrx.html.

Express Scripts Holding Company (ESRX) opened at 62.69 on Thursday. The stock has a market capitalization of $36.21 billion, a P/E ratio of 10.88 and a beta of 0.88. The company has a 50 day moving average of $61.84 and a 200 day moving average of $63.54. Express Scripts Holding Company has a 52 week low of $57.80 and a 52 week high of $77.50.

Express Scripts Holding (NASDAQ:ESRX) last posted its earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. The firm had revenue of $25.35 billion during the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.57 EPS. Equities analysts expect that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.

Several equities research analysts have issued reports on ESRX shares. BidaskClub upgraded shares of Express Scripts Holding from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Robert W. Baird reiterated a “hold” rating and set a $56.00 target price on shares of Express Scripts Holding in a research report on Friday, September 1st. Needham & Company LLC started coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They set a “hold” rating for the company. ValuEngine lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Finally, Cowen and Company reiterated an “outperform” rating and set a $83.00 target price on shares of Express Scripts Holding in a research report on Friday, June 9th. Four equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Express Scripts Holding presently has a consensus rating of “Hold” and an average price target of $70.24.

In related news, VP Everett Neville sold 1,163 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total value of $71,501.24. Following the completion of the sale, the vice president now directly owns 18,232 shares in the company, valued at $1,120,903.36. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.68% of the stock is owned by company insiders.

Express Scripts Holding Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.